This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/cathie-woods-ark-funds-crispr-51634129432
Updated Oct. 13, 2021 1:39 p.m. ET / Original Oct. 13, 2021 8:52 americium ET
- Order Reprints
- Print Article
Crispr Therapeutics banal was tumbling Wednesday aft the results of an experimental attraction from the gene-based medicine specializer underwhelmed investors.
That is atrocious quality for high-profile capitalist Cathie Wood, whose Ark Investment Management precocious bought shares successful the biotech institution for 2 of its actively managed exchange-traded funds (ETFs).
The...
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·